Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415293 · ClinicalTrials.gov registry record · NA
Commerical DHA Supplementation
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT05415293: Clinical Trial NA study, sponsored by University of New Mexico.
NCT05415293 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05415293, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to compare blood levels of women who take commericially available, low dose docosahexaenoic acid (DHA) dietary supplements in pregnancy with women who do not take supplements.
Primary Outcome
Weight proportion of DHA in the total plasma phospholipids after supplementation
Interventions
- DIETARY_SUPPLEMENT Expecta 200mg DHA
- DIETARY_SUPPLEMENT Promise 275mg DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-05 |
| Phase | NA |
Why NCT05415293 stopped before completion
NCT05415293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Expecta 200mg DHA is the first listed.
NCT05415293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05415293 about?
NCT05415293 is a clinical study titled "Commerical DHA Supplementation". The purpose of this study is to compare blood levels of women who take commericially available, low dose docosahexaenoic acid (DHA) dietary supplements in pregnancy with women who do not take supplements.
What is the current status of trial NCT05415293?
This trial is currently terminated. It is a NA study. The enrollment target is 72 participants. The study started on 2011-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT05415293?
The interventions under investigation include: Expecta 200mg DHA (DIETARY_SUPPLEMENT), Promise 275mg DHA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05415293?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05415293's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia